Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You-Cheol Hwang

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Scientific Reports|June 28, 2024
Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohortsHyunji Sang, Hojae Lee, Myeongcheol Lee, et al.
Plos One|March 28, 2013
Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009Sang Ouk Chin, Sang Youl Rhee, Suk Chon, et al.
Diabetes & Metabolism Journal|November 8, 2013
Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetesSang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, et al.
Plos One|July 9, 2026
Machine learning for predicting emergency department visits in patients with type 2 diabetes: A real-world, multi-institutional studySunyoung Kim, Hyunji Sang, Jaeyu Park, et al.
Journal of Yeungnam Medical Science|September 30, 2025
Experiences of healthcare providers and patients with diabetes mellitus regarding continuous glucose monitoring use in South Korea: a multicenter, cross-sectional survey studyYoung-Jin Choi, Jung-Hwa Lee, Kyu-Jeung Ahn, et al.
Diabetes & Metabolism Journal|October 28, 2025
Efficacy and Safety of High-Dose Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialJun Hwa Hong, Kyung Ah Han, You-Cheol Hwang, et al.
Diabetes, Obesity & Metabolism|July 9, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 studyKyung Ah Han, You-Cheol Hwang, Shin Je Moon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2016
Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled TrialSang-Man Jin, Kyung Ah Han, Jae Myung Yu, et al.
Diabetes, Obesity & Metabolism|March 26, 2026
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III TrialSoo Lim, Tae Nyun Kim, Ji Oh Mok, et al.
Diabetes & Metabolism Journal|November 29, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes AssociationJaehyun Bae, Eugene Han, Hye Won Lee, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Scientific Reports|June 28, 2024
Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohortsHyunji Sang, Hojae Lee, Myeongcheol Lee, et al.
Plos One|March 28, 2013
Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009Sang Ouk Chin, Sang Youl Rhee, Suk Chon, et al.
Diabetes & Metabolism Journal|November 8, 2013
Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetesSang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, et al.
Plos One|July 9, 2026
Machine learning for predicting emergency department visits in patients with type 2 diabetes: A real-world, multi-institutional studySunyoung Kim, Hyunji Sang, Jaeyu Park, et al.
Journal of Yeungnam Medical Science|September 30, 2025
Experiences of healthcare providers and patients with diabetes mellitus regarding continuous glucose monitoring use in South Korea: a multicenter, cross-sectional survey studyYoung-Jin Choi, Jung-Hwa Lee, Kyu-Jeung Ahn, et al.
Diabetes & Metabolism Journal|October 28, 2025
Efficacy and Safety of High-Dose Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialJun Hwa Hong, Kyung Ah Han, You-Cheol Hwang, et al.
Diabetes, Obesity & Metabolism|July 9, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 studyKyung Ah Han, You-Cheol Hwang, Shin Je Moon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2016
Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled TrialSang-Man Jin, Kyung Ah Han, Jae Myung Yu, et al.
Diabetes, Obesity & Metabolism|March 26, 2026
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III TrialSoo Lim, Tae Nyun Kim, Ji Oh Mok, et al.
Diabetes & Metabolism Journal|November 29, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes AssociationJaehyun Bae, Eugene Han, Hye Won Lee, et al.
Pageof 12